Recombinant tissue plasminogen activators (rtPA): a review (Q34462146)

2 August 2017

1 reference

title

Recombinant tissue plasminogen activators (rtPA): a review (English)

1 reference

2 August 2017

1 reference

P Gurman

1

1 reference

2 August 2017

O R Miranda

2

1 reference

2 August 2017

A Nathan

3

1 reference

2 August 2017

C Washington

4

1 reference

2 August 2017

Y Rosen

5

1 reference

2 August 2017

N M Elman

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

31 January 2015

1 reference

Clinical Pharmacology & Therapeutics

2 August 2017

published in

1 reference

2 August 2017

volume

97

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

274-285

1 reference

2 August 2017

cites work

The hemostatic system

1 reference

Mechanisms of thrombus formation

21 January 2018

1 reference

Basic mechanisms and pathogenesis of venous thrombosis

21 January 2018

1 reference

The tissue-type plasminogen activator story

21 January 2018

1 reference

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

21 January 2018

1 reference

Hypercoagulable states: a review

21 January 2018

1 reference

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

Recombinant tissue-type plasminogen activators: "time matters"

21 January 2018

1 reference

Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities

21 January 2018

1 reference

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

21 January 2018

1 reference

21 January 2018

Tenecteplase: a review

1 reference

The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions

21 January 2018

1 reference

The neurotoxicity of tissue plasminogen activator?

21 January 2018

1 reference

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

Interventional management of acute ischemic stroke: a systematic review

21 January 2018

1 reference

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis.

21 January 2018

1 reference

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

21 January 2018

1 reference

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

21 January 2018

1 reference

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction

21 January 2018

1 reference

Pulmonary embolism: risk assessment and management

21 January 2018

1 reference

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association

21 January 2018

1 reference

Therapy for acute high-risk pulmonary embolism: thrombolytic therapy and embolectomy

21 January 2018

1 reference

Frostbites in circumpolar areas

21 January 2018

1 reference

Using thrombolytics in frostbite injury

21 January 2018

1 reference

Wilderness Medical Society Practice Guidelines for the Prevention and Treatment of Frostbite

21 January 2018

1 reference

An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite

21 January 2018

1 reference

Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis

21 January 2018

1 reference

Magnetic nanoparticles: synthesis, protection, functionalization, and application

21 January 2018

1 reference

Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.

21 January 2018

1 reference

Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator

21 January 2018

1 reference

Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis

21 January 2018

1 reference

Development of a miniaturised drug delivery system with wireless power transfer and communication.

21 January 2018

1 reference

Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model.

21 January 2018

1 reference

Advanced multimodal CT/MRI approaches to hyperacute stroke diagnosis, treatment, and monitoring

21 January 2018

1 reference

Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review

21 January 2018

1 reference

Ultrasound identification and lysis of clots.

21 January 2018

1 reference

IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.

21 January 2018

1 reference

Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism

21 January 2018

1 reference

Elements of the fibrinolytic system

21 January 2018

1 reference

7 January 2021

Intra-arterial Therapy for Acute Ischemic Stroke

1 reference

7 January 2021

Acute pulmonary embolism treated with tissue plasminogen activator

1 reference

7 January 2021

The role of recombinant human tissue-type plasminogen activator in the treatment of acute pulmonary thromboembolism

1 reference

7 January 2021

A Controlled Trial of a Prostacyclin and rt-PA in the Treatment of Severe Frostbite

1 reference

7 January 2021

An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care

1 reference

7 January 2021

Translational medicine for stroke drug discovery: the pharmaceutical industry perspective

1 reference

7 January 2021

Identifiers

DOI

10.1002/CPT.33

1 reference

2 August 2017

1 reference